Literature DB >> 2364847

Capnocytophaga infection involving a portal-systemic vascular shunt.

K A Mello1, D R Snydman, S Arora.   

Abstract

Capnocytophaga sp., a microaerophilic gram-negative isolate of the human oral cavity, has previously been reported to cause sinusitis, empyema, wound infections, conjunctivitis, subphrenic abscess, osteomyelitis, bacteremia, cervical abscess, and endocarditis. We report the unusual case of infection with this organism at the anastamotic site of a splenorenal portosystemic vascular shunt. In this case, the pathogenesis is presumed to be bacteremia related to mucosal trauma from endoscopic injection sclerotherapy or bacteremia secondary to dental infection. The characteristics and antibiotic sensitivities of Capnocytophaga are reviewed.

Entities:  

Mesh:

Year:  1990        PMID: 2364847     DOI: 10.1007/bf01536808

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  Spontaneous bacterial peritonitis: an explosion of information.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

2.  Infectious complications of endoscopic injection sclerotherapy.

Authors:  D E Low; J P Shoenut; J K Kennedy; G K Harding; B Den Boer; A B Micflikier
Journal:  Arch Intern Med       Date:  1986-03

3.  In vitro susceptibility of Capnocytophaga species to antimicrobial agents.

Authors:  P M Hawkey; S D Smith; J Haynes; H Malnick; S W Forlenza
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

4.  Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts.

Authors:  D M Parenti; D R Snydman
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

5.  Antimicrobial susceptibility of Capnocytophaga.

Authors:  S W Forlenza; M G Newman; A L Horikoshi; U Blachman
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

Review 6.  Bacteremia with gastrointestinal endoscopic procedures.

Authors:  V A Botoman; C M Surawicz
Journal:  Gastrointest Endosc       Date:  1986-10       Impact factor: 9.427

7.  Bacteremia after endoscopic injection sclerosis.

Authors:  L B Cohen; M A Korsten; E J Scherl; M E Velez; R D Fisse; E J Arons
Journal:  Gastrointest Endosc       Date:  1983-08       Impact factor: 9.427

8.  Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.

Authors:  A Rimola; F Bory; J Teres; R M Perez-Ayuso; V Arroyo; J Rodes
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

9.  Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1.

Authors:  M G Newman; V L Sutter; M J Pickett; U Blachman; J R Greenwood; V Grinenko; D Citron
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

10.  In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.

Authors:  G Arlet; M J Sanson-Le Pors; I M Casin; M Ortenberg; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.